[Allogeneic umbilical cord blood transplantation in overweight patients: evaluation of outcome, alloreactivity and morbidity. Preliminary results of a phase I study].
Romero
R
R
Servicio de Hematologia, Clinica Puerta de Hierro, UAM, Madrid.
Cabrera
R
R
Regidor
C
C
Sanjuán
I
I
Forés
R
R
Briz
M
M
Steegmann
J L
JL
Bañas
H
H
Fernández
M N
MN
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications / Q000628:therapy; D001772:Blood Cell Count; D005199:Fanconi Anemia / Q000150:complications; D017809:Fatal Outcome; D005260:Female; D005312:Fetal Blood / Q000166:cytology*; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006412:Hematopoietic Stem Cells / Q000276:immunology; D006648:Histocompatibility; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000628:therapy; D007951:Leukemia, Myeloid / Q000150:complications / Q000628:therapy; D009765:Obesity / Q000150:complications; D010865:Pilot Projects; D016896:Treatment Outcome
D006680:HLA Antigens